Literature DB >> 201886

Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy.

S Carpenter, G Karpati, I Heller, A Eisen.   

Abstract

We report six cases of inclusion body myositis (IBM), a distinct but infrequently recognized inflammatory disease of skeletal muscle. Clinically, IBM differs from dermatomyositis and polymyositis. It lacks features of collagen-vascular disease, has a relatively benign and protracted course, frequently involves distal muscles, is found mainly in males, and does not improve with corticosteroid treatment. Electronmicroscopic demonstration of abnormal filaments in muscle cells is necessary for definite diagnosis, but IBM may be suspected by the finding on cryostat sections of numerous hematoxylinophilic granules in "lined" vacuoles in muscle cells. These correspond to whorls of cytomembranes. Although in dermatomyositis the capillary network is partly destroyed, in IBM it is usually augmented. A viral etiology of IBM has been suggested but remains unproven.

Entities:  

Mesh:

Year:  1978        PMID: 201886     DOI: 10.1212/wnl.28.1.8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

1.  Inclusion Body Myositis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  Fast and reliable new method for electron-microscopic identification of cytoplasmic tubulo-filaments in muscle biopsies of patients with inclusion-body myositis.

Authors:  V Askanas; R B Alvarez
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

4.  Intranuclear and cytoplasmic filamentous inclusions in distal myopathy (Welander).

Authors:  K Borg; F M Tomé; L Edström
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Mitochondrial genome: defects, disease, and evolution.

Authors:  A Clarke
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

Review 6.  A rare association of early-onset inclusion body myositis, rheumatoid arthritis and autoimmune thyroiditis: a case report and literature review.

Authors:  A M Clerici; G Bono; M L Delodovici; G Azan; G Cafasso; G Micieli
Journal:  Funct Neurol       Date:  2013 Apr-May

7.  Glucocorticoid-sensitive hereditary inclusion body myositis.

Authors:  M Naumann; H Reichmann; H H Goebel; C Moll; K V Toyka
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

Review 8.  Novel Therapeutic Options in Treatment of Idiopathic Inflammatory Myopathies.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2018-07-23       Impact factor: 3.598

9.  Intranuclear inclusions in muscle, nervous tissue, and adrenal gland.

Authors:  J Tateishi; H Nagara; M Ohta; T Matsumoto; H Fukunaga; K Shida
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis.

Authors:  J Nalbantoglu; G Karpati; S Carpenter
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.